Neogenomics (NEO) Accounts Payables (2010 - 2026)

Neogenomics (NEO) has reported Accounts Payables for 17 consecutive years, with $25.9 million the latest figure, recorded in Q1 2026.

• Accounts Payables for Q1 2026 came in at $25.9 million, up 59.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.9 million (up 59.76% YoY), and the FY2025 annual result was $23.1 million, up 6.86% from the prior year.
• Accounts Payables was $25.9 million for Q1 2026 at Neogenomics, up from $23.1 million in the prior quarter.
• Over five years, Accounts Payables peaked at $27.5 million in Q2 2025 and troughed at $13.7 million in Q3 2022.
• Average Accounts Payables over 5 years is $19.9 million, with a median of $20.3 million recorded in 2023.
• Year-over-year, Accounts Payables plunged 51.96% in 2022 and surged 59.97% in 2025.
• Over 5 years, Accounts Payables stood at $20.5 million in 2022, then declined by 0.86% to $20.3 million in 2023, then grew by 6.26% to $21.6 million in 2024, then climbed by 6.86% to $23.1 million in 2025, then gained by 12.16% to $25.9 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $25.9 million in Q1 2026, $23.1 million in Q4 2025, and $22.6 million in Q3 2025.